Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United Kingdom Children’s doctors back calls for a ban on disposables…
  • United States Elf maker VPR wants order banning Elf Bar sales upheld…
  • World WHO chief tells nations to guard against the ‘trap’ of e-cigarettes…
  • Bangladesh Big tax rises proposed in bid to reduce vaping…
  • Birthdate-based e-cig ban back on Parliament agenda…
  • United States NACS reiterates plea to FDA for a public list of legal e-cig products…
  • South Africa Committee shows mixed reactions to tobacco control bill…
  • Europe EC answers MEP question over possible conflict of interest…
  • Ukraine Resolution published on restricting minors’ access to e-cig websites…
  • Russia State Duma passes bill to regulate production and distribution…
  • Dominican Republic Health minister urges young people to quit vaping…
  • Spain MEPs call for EU-wide public vaping ban…
View all
News analysis

New and unapproved? FDA inspectors could have plenty to look at

Written by || 7th March 2018 || News analysis || Regulation and Legislation | North America United States

There may be widespread disregard of US FDA rules around the introduction of new vapour products and a new inspection regime may have its hands full, ECigIntelligence research suggests ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA extends PMTA deadline by nearly four years
Maker claims FDA statement “frees synthetic nicotine from deeming”
FDA faces constitutional challenge to deeming rule in several courts at once